Previous 10 | Next 10 |
2024-05-10 07:01:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The world of nanotechnology relies on the mastery of the molecular scale. Thus, companies that thrive on the production of materials and chemical interactions at the atomic level could someday ...
2024-05-07 14:45:56 ET More on Bruker, 10x Genomics, etc. Bruker Corporation (BRKR) Q1 2024 Earnings Call Transcript Bruker Corporation 2024 Q1 - Results - Earnings Call Presentation 10x Genomics, Inc. (TXG) Q1 2024 Earnings Call Transcript Bruker Non-GAAP EP...
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference PR Newswire PLEASANTON, Calif. , May 2, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its managemen...
A look at the top 10 most actives in the United States Akanda Corp. (AKAN) rose 52.9% to $0.1422 on volume of 108,274,564 shares CytomX Therapeutics Inc. (CTMX) rose 71.8% to $2.8 on volume of 31,588,176 shares Getaround Inc. (GETR) rose 35.9% to $0.2754 on volume of 26,693,135 shares P...
2024-05-01 06:00:03 ET Luke Sergott from Barclays issued a price target of $36.00 for TXG on 2024-05-01 05:08:00. The adjusted price target was set to $36.00. At the time of the announcement, TXG was trading at $29.28. The overall price target consensus is at $47.50 with...
2024-04-30 23:32:01 ET 10x Genomics, Inc. (TXG) Q1 2024 Earnings Conference Call April 30, 2024 16:30 ET Company Participants Cassie Corneau - Director of Investor Relations & Strategic Finance Serge Saxonov - Chief Executive Officer & Co-Founder Justin M...
2024-04-30 17:01:17 ET Gainers: Powell Industries ( POWL ) +19% . Root ( ROOT ) +16% . TransMedics Group ( TMDX ) +11% . Inari Medical ( NARI ) +7% . MannKind Corporation ( MNKD ) +5% . Losers: CVRx ( CVRX ) -16% ...
2024-04-30 16:53:43 ET More on 10x Genomics 10x Genomics, Inc. (TXG) Q4 2023 Earnings Call Transcript 10x Genomics Q1 2024 Earnings Preview 10x Genomics begins shipping Chromium GEM-X products Seeking Alpha’s Quant Rating on 10x Genomics Histor...
10x Genomics Reports First Quarter 2024 Financial Results PR Newswire PLEASANTON, Calif. , April 30, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter end...
2024-04-29 17:20:31 ET More on 10x Genomics 10x Genomics, Inc. (TXG) Q4 2023 Earnings Call Transcript 10x Genomics begins shipping Chromium GEM-X products 10x Genomics GAAP EPS of -$0.41 misses by $0.05, revenue of $184M beats by $0.26M Seeking Alpha’s...
News, Short Squeeze, Breakout and More Instantly...
2024-06-28 07:15:04 ET Barclays analyst issues OVERWEIGHT recommendation for TXG on June 28, 2024 05:28AM ET. The previous analyst recommendation was Overweight. TXG was trading at $19.85 at issue of the analyst recommendation. The overall analyst consensus : HOLD. C...
New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies PR Newswire Researchers used Chromium Single Cell products and Xenium In Situ to profile how gene expression is spatially regulated during secondary palate formation PLEASAN...
2024-06-27 06:15:04 ET Wolfe Research analyst issues PEER PERFORM recommendation for TXG on June 27, 2024 04:49AM ET. TXG was trading at $19.5 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 3 - Buy, 5 -...